FDA — authorised 8 May 2014
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: approved
🇺🇸 Zontivity in United States
FDA authorised Zontivity on 8 May 2014
Marketing authorisations
FDA — authorised 8 May 2014
- Application: NDA204886
- Marketing authorisation holder: KEY THERAP
- Local brand name: ZONTIVITY
- Indication: TABLET — ORAL
- Status: approved
Zontivity in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Zontivity approved in United States?
Yes. FDA authorised it on 8 May 2014; FDA authorised it on 8 May 2014.
Who is the marketing authorisation holder for Zontivity in United States?
MERCK SHARP DOHME holds the US marketing authorisation.